|
51
|
172
|
7l0lB |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
18
|
120
|
7l0lG |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
63
|
322
|
7l0lA |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
17
|
108
|
7l0lJ |
Cryo-em structure of the vrc316 clinical trial, vaccine-elicited, human antibody 316-310-1b11 in complex with an h2 can05 ha trimer |
|
28
|
198
|
7n6eG |
Tcr peptide hla-a2 complex |
|
49
|
219
|
7n3iH |
Crystal structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment c098 |
|
50
|
213
|
7n3iL |
Crystal structure of the sars-cov-2 receptor binding domain in complex with the human neutralizing antibody fab fragment c098 |
|
20
|
213
|
7mlzL |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
47
|
216
|
7mmnE |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
84
|
373
|
7mmnB |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
11
|
122
|
7mm0H |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
20
|
222
|
7mlzH |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
180
|
1136
|
7mm0A |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
11
|
72
|
7mmnA |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
10
|
107
|
7mm0L |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
44
|
222
|
7mmnD |
Crystal structure of the prefusion rsv f glycoprotein bound by human antibody am14 |
|
61
|
274
|
7n6eA |
Tcr peptide hla-a2 complex |
|
14
|
99
|
7n6dB |
Hla peptide complex |
|
75
|
275
|
7n6dA |
Hla peptide complex |
|
12
|
99
|
7n6eB |
Tcr peptide hla-a2 complex |
|
49
|
239
|
7n6eH |
Tcr peptide hla-a2 complex |
|
20
|
196
|
7mlzA |
Cryo-em structure of sars-cov-2 spike in complex with neutralizing antibody b1-182.1 that targets the receptor-binding domain |
|
49
|
322
|
6xskA |
Cryo-em structure of vaccine-elicited rhesus vh6-1 antibody 789-203-3c12 in complex with stabilized si06 (a/solomon islands/3/06) influenza hemagglutinin trimer |
|
49
|
167
|
6xskB |
Cryo-em structure of vaccine-elicited rhesus vh6-1 antibody 789-203-3c12 in complex with stabilized si06 (a/solomon islands/3/06) influenza hemagglutinin trimer |
|
17
|
125
|
6xskG |
Cryo-em structure of vaccine-elicited rhesus vh6-1 antibody 789-203-3c12 in complex with stabilized si06 (a/solomon islands/3/06) influenza hemagglutinin trimer |
|
15
|
107
|
6xskJ |
Cryo-em structure of vaccine-elicited rhesus vh6-1 antibody 789-203-3c12 in complex with stabilized si06 (a/solomon islands/3/06) influenza hemagglutinin trimer |
|
192
|
1124
|
7my2B |
Cryoem structure of neutralizing nanobody nb30 in complex with sars-cov2 spike |
|
185
|
1128
|
7my3A |
Cryoem structure of neutralizing nanobody nb12 in complex with sars-cov2 spike |
|
17
|
120
|
7my3D |
Cryoem structure of neutralizing nanobody nb12 in complex with sars-cov2 spike |
|
19
|
120
|
7my2A |
Cryoem structure of neutralizing nanobody nb30 in complex with sars-cov2 spike |
|
42
|
227
|
7dk0A |
Crystal structure of sars-cov-2 spike rbd in complex with mw05 fab |
|
47
|
197
|
7djzC |
Crystal structure of sars-cov-2 spike rbd in complex with mw01 fab |
|
43
|
210
|
7dk0B |
Crystal structure of sars-cov-2 spike rbd in complex with mw05 fab |
|
40
|
195
|
7dk0C |
Crystal structure of sars-cov-2 spike rbd in complex with mw05 fab |
|
47
|
225
|
7djzA |
Crystal structure of sars-cov-2 spike rbd in complex with mw01 fab |
|
51
|
213
|
7djzB |
Crystal structure of sars-cov-2 spike rbd in complex with mw01 fab |
|
99
|
464
|
7llkA |
Cryo-em structure of q23.17_ds-sosip in complex with glycan276-dependent broadly neutralizing antibody 179nc75 fab |
|
39
|
144
|
7llkB |
Cryo-em structure of q23.17_ds-sosip in complex with glycan276-dependent broadly neutralizing antibody 179nc75 fab |
|
17
|
131
|
7llkC |
Cryo-em structure of q23.17_ds-sosip in complex with glycan276-dependent broadly neutralizing antibody 179nc75 fab |
|
15
|
104
|
7llkD |
Cryo-em structure of q23.17_ds-sosip in complex with glycan276-dependent broadly neutralizing antibody 179nc75 fab |
|
0
|
5
|
6x78G |
Vaccine-elicited mouse fp-targeting neutralizing antibody vfp48.03 in complex with hiv fusion peptide (residue 512-519) |
|
52
|
218
|
6x78A |
Vaccine-elicited mouse fp-targeting neutralizing antibody vfp48.03 in complex with hiv fusion peptide (residue 512-519) |
|
49
|
213
|
6x7wC |
Vaccine-elicited mouse fp-targeting neutralizing antibody vfp49.02 in complex with hiv fusion peptide (residue 512-519) |
|
42
|
223
|
6x78B |
Vaccine-elicited mouse fp-targeting neutralizing antibody vfp48.03 in complex with hiv fusion peptide (residue 512-519) |
|
42
|
224
|
6x7wA |
Vaccine-elicited mouse fp-targeting neutralizing antibody vfp49.02 in complex with hiv fusion peptide (residue 512-519) |
|
77
|
274
|
7mkbA |
Human leukocyte antigen a*0201 in complex with sars-cov-2 epitope ylqprtfll |
|
14
|
100
|
7mkbB |
Human leukocyte antigen a*0201 in complex with sars-cov-2 epitope ylqprtfll |
|
33
|
228
|
6xpyB |
Human antibody s1v2-58 in complex with the influenza hemagglutinin head domain of a/texas/50/2012(h3n2) |
|
48
|
216
|
6xpxB |
Human antibody s1v2-51 in complex with the influenza hemagglutinin head domain of a/aichi/2/1968 (x-31)(h3n2) |
|
40
|
212
|
6xpyC |
Human antibody s1v2-58 in complex with the influenza hemagglutinin head domain of a/texas/50/2012(h3n2) |
